ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)

ClinicalTrials.gov ID: NCT04630028

Public ClinicalTrials.gov record NCT04630028. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Open-label Intravenous Induction Treatment Followed by Randomized Double-blind Subcutaneous Ustekinumab Maintenance in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

Study identification

NCT ID
NCT04630028
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
112 participants

Conditions and interventions

Interventions

  • Matching Placebo Drug
  • Ustekinumab Dose Based on BSA and Body Weight Drug

Drug

Eligibility (public fields only)

Age range
2 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2021
Primary completion
May 7, 2025
Completion
Jun 4, 2025
Last update posted
May 13, 2026

2021 – 2025

United States locations

U.S. sites
9
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
Nemours DuPont Hospital for Children Wilmington Delaware 19803
Children's Center for Digestive Health Care Atlanta Georgia 30342
Mayo Clinic Rochester Minnesota 55905
Morristown Memorial Hospital Morristown New Jersey 07962
Levine Childrens at Atrium Health Charlotte North Carolina 28207
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Penn State Hershey Children's Hospital Hershey Pennsylvania 17033
Cook Childrens Medical Center Fort Worth Texas 76104
Pediatric Specialists Of Virginia Fairfax Virginia 22031

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04630028, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04630028 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →